100
Participants
Start Date
February 23, 2022
Primary Completion Date
April 30, 2026
Study Completion Date
July 31, 2026
Intravenous patient-control analgesia
At the two trial sites, IV-PCA is commonly used with morphine. The device is installed after delivery and removed within 3 days.
Dinalbuphine sebacate
Dinalbuphine sebacate is a prodrug of nalbuphine. With oil-based formulation, the active ingredient releases slowly and the effect lasts longer than nalbuphine. After delivery, a single 150 mg dose of dinalbuphine sebacate is administered intramuscularly.
NOT_YET_RECRUITING
MacKay Memorial Hospital, Taipei
RECRUITING
MacKay Memorial Hospital Tamsui Branch, New Taipei City
Mackay Memorial Hospital
OTHER